CLINICAL TRIALS PROFILE FOR EC-NAPROSYN
✉ Email this page to a colleague
All Clinical Trials for Ec-naprosyn
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00153660 ↗ | Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients | Completed | Chinese University of Hong Kong | Phase 3 | 2005-06-01 | The aim of this study is to compare celecoxib plus a PPI (esomeprazole) versus naproxen plus a PPI (esomeprazole) in preventing recurrent ulcer bleeding in arthritis patients with a history of ulcer bleeding who require concomitant ASA. We hypothesized that among patients with a history of ulcer bleeding who require concomitant ASA, celecoxib plus esomprazole would be superior to naproxen plus esomeprazole for the prevention of recurrent ulcer bleeding. |
NCT00303017 ↗ | Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study | Completed | Primus Pharmaceuticals | N/A | 2006-03-01 | safety, efficacy and acceptability of Flavocoxid |
NCT00383487 ↗ | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | Terminated | Novacea | Phase 2 | 2005-03-01 | To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ec-naprosyn
Condition Name
Clinical Trial Locations for Ec-naprosyn
Trials by Country
Clinical Trial Progress for Ec-naprosyn
Clinical Trial Phase
Clinical Trial Sponsors for Ec-naprosyn
Sponsor Name